Structure and inhibition of SARS-CoV-2 spike refolding in membranes.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 39146425.
- Also identified by DOI 10.1126/science.adn5658 and PMC identifier 11449073.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein binds the receptor angiotensin converting enzyme 2 (ACE2) and drives virus-host membrane fusion through refolding of its S2 domain. Whereas the S1 domain contains high sequence variability, the S2 domain is conserved and is a promising pan-betacoronavirus vaccine target. We applied cryo-electron tomography to capture intermediates of S2 refolding and understand inhibition by antibodies to the S2 stem-helix. Subtomogram averaging revealed ACE2 dimers cross-linking spikes before transitioning into S2 intermediates, which were captured at various stages of refolding. Pan-betacoronavirus neutralizing antibodies targeting the S2 stem-helix bound to and inhibited refolding of spike prehairpin intermediates. Combined with molecular dynamics simulations, these structures elucidate the process of SARS-CoV-2 entry and reveal how pan-betacoronavirus S2-targeting antibodies neutralize infectivity by arresting prehairpin intermediates.
Medical subject headings
- Spike Glycoprotein, Coronavirus
- SARS-CoV-2
- Angiotensin-Converting Enzyme 2
- Molecular Dynamics Simulation
- Antibodies, Neutralizing
- Cryoelectron Microscopy
- Antibodies, Viral
- Protein Domains